CDRI

CSIR-Central Drug Research Institute, Lucknow, a premier Institute under Council of Scientific and Industrial Research (CSIR), is involved in the multidisciplinary R&D programs of both basic and applied nature. CSIR-CDRI is a pioneer biomedical research organization in India and has the infrastructure and expertise to develop a drug right from the concept stage to the commercialization.

Applications are invited from Indian nationals for the project No: TCOF 9 “CDRI-830 Analogs Synthesis and Bioevaluation” for a period of six months and will be extended for another six months subject to review.

Post: Project Fellow

CSIR-Central Drug Research Institute, Lucknow has instituted CDRI Awards in the year 2004 to recognize scientific excellence in the country in the area of Drug Research and Development. There are two separate individual awards each for the area of Chemical Sciences and Life Sciences. These awards are given annually to the Indian Nationals of below 45 years who have carried out outstanding research work in the area having direct bearing on Drug Research and Development.

CSIR-Central Drug Research Institute, Lucknow, a constitute laboratory of the Council of Scientific and Industrial Research (CSIR) is a pioneer biomedical research organization in India. It has the infrastructure and expertise to develop a drug right from the concept stage to the commercialization. The institute’s latest techniques and services are employed for developing drugs, diagnostics and vaccines to combat diseases prevalent among mankind in general and Indian population in particular.

CSIR- Central Drug Research Institute (CSIR-CDRI), a premier drug research institute of India was inaugurated on 17th Feb 1951 by the then Prime Minister of India Pt. Jawaharlal Nehru with a vision to strengthen and advance the field of drug research and development in the country. The Institute has made significant accomplishments in the pursuit of its mission to New Drugs & Technologies for affordable healthcare for all, generation of knowledge base and nurturing future leaders for healthcare sector. Today, it has become a unique model for modernized drug research in India – having everything under one roof, from synthesis, screening, development studies, process up-scaling to clinical studies. Unique achievements of the Institute includes discovery and development of 12 new drugs, of which, Arteether (Brand Name: E-mal), BESEB (Brand Name: Memory Sure), Centchroman (Brand Name: Saheli) are currently in market; transferred more than 130 indigenous technologies to the pharmaceutical companies, a significant contribution in the metamorphosis of the Indian Pharma Industry. So far, more than 10,000 research articles have been published by the Institute in peer reviewed journals. Obtained more than 350 Indian patents and 90 international patents; and produced more than 1000 Ph.D's. Several of its Alumni have occupied highest positions in national and international academic institutions, biotech and pharma industries.

ADMISSION TO Ph.D. PROGRAMMES FOR ACADEMIC SESSION JAN. 2016

Researchers are invited to participate in a three days Brain-Storming meet entitled “Renewing the tradition of natural product research in India” - organized by CSIR-Central Drug Research Institute, Lucknow with select participation of past stalwarts and current researchers.

CSIR-CDRI The premier Drug Research Institute in the country invites application for full time Ph.D in the relevant areas of research in the institute. Institute has robust Ph.D programme and provides vibrant academic atmosphere enabling inter disciplinary and cross disciplinary areas of research.

The National Institute of Pharmaceutical Education and Research (NIPER) has been created as a centre of excellence for higher education, research and development in pharmaceutical sciences. NIPER, Rae Bareli at ITI campus, Rae Bareli under the mentor Institute of CSIR-Central Drug Research Institute, Lucknow invites eligible candidates for following positions on purely temporary basis on contract initially for a period of 3 years which may be extended further for another 2 years based on performance on the existing terms and conditions of the offer. The selected candidates shall have no claim for regularization implicitly / explicitly against any regular post either in NIPER or CDRI.

Post: Assistant Professor